Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,495.57
    -934.98 (-1.82%)
     
  • CMC Crypto 200

    1,321.12
    -75.42 (-5.40%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

What’s behind Nektar Therapeutics’ ~38% Fall in June?

What’s behind Nektar Therapeutics’ ~38% Fall in June?

On June 27, Nektar Therapeutics (NKTR) ended the trading day at a closing price of $46.25. On the day, NKTR stock was trading ~164% higher than the 52-week low of $17.51 it reported on August 21, whereas the stock was trading ~59% lower than the 52-week high of $111.36 it reported on March 12. Currently, NKTR stock is trading lower than its 50-day moving average of $67.63 and its 200-day moving average of $79.32.